Results 261 to 270 of about 7,805 (301)
Some of the next articles are maybe not open access.
Methodology in anti-emetic trials.
European journal of cancer (Oxford, England : 1990), 1991Major progress in the ability to control chemotherapy-induced emesis has been made over the past 10 years. One of the several factors contributing to this improved control has been the development of accurate assessment methodology. The application of proper study methodology fostered the identification of active single agents and led to the formation ...
R J, Gralla +3 more
openaire +1 more source
Emetics and antiemetics are two classes of medications that serve opposite purposes in managing nausea and vomiting. Emetics, such as ipecac syrup, induce vomiting and are used primarily in certain poisoning cases to expel ingested toxins from the stomach. However, their use has declined due to the potential risks and the availability of more effective
openaire +1 more source
openaire +1 more source
Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins
Nature Reviews Molecular Cell Biology, 2021Ning Jia, Dinshaw J Patel
exaly
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Nature Reviews Clinical Oncology, 2021Michael Karin
exaly
Anti-obesity drug discovery: advances and challenges
Nature Reviews Drug Discovery, 2021Timo D Müller +2 more
exaly
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
Nature Reviews Clinical Oncology, 2018Kabir A Khan, Robert S Kerbel
exaly
An outline of anti-emetic treatment.
European journal of cancer & clinical oncology, 1990With the advent of new chemotherapeutic agents, and their well-known side effect of emesis, the need for a greater facility with anti-emetics has emerged. As well as the common problem of chemotherapy-induced emesis, other problems have become apparent such as delayed emesis and anticipatory emesis.
openaire +1 more source